SCHEMBL29532897

SCHEMBL29532897

O=C1Nc2cccc3c(Br)ccc(c23)N1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1B1 Q16678 13/20 0.39
▸ PARP1 P09874 1/20 0.39
▸ S1PR2 O95136 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.36
▸ POLB P06746 2/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ PABPC1 P11940 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CCNB2 O95067 1/20 0.36
▸ CDK1 P06493 1/20 0.36
▸ CCNB1 P14635 1/20 0.36
▸ GSK3B P49841 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24317908 1.00 CYP1B1 (0.39) CYP1B1PARP1S1PR2TP53MAPK1
SCHEMBL7118963 0.78 CDK5 (0.54) PARP1ALDH1A1POLBKDM4EMEN1
SCHEMBL29532065 0.78 KDR (0.48) CYP1B1PARP1ALDH1A1POLBRXFP1
SCHEMBL8482582 0.78 KDR (0.48) CYP1B1PARP1ALDH1A1POLBRXFP1
SCHEMBL29532763 0.75 AHR (0.50) TP53MAPK1ALDH1A1KDM4EMEN1
SCHEMBL24317852 0.75 AHR (0.50) TP53MAPK1ALDH1A1KDM4EMEN1
SCHEMBL24317408 0.74 CYP1B1 (0.38) CYP1B1PARP1S1PR2TP53MAPK1
SCHEMBL24317400 0.74 CYP1B1 (0.35) CYP1B1PARP1S1PR2TP53MAPK1
SCHEMBL29532711 0.74 CYP1B1 (0.38) CYP1B1PARP1S1PR2TP53MAPK1
SCHEMBL4199390 0.70 RAD52 (0.52) CYP1B1PARP1MAPK1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4228624-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 Therapeutics, Inc. (US) 2023-08-23 — — EP disclosed
WO-2022081927-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 THERAPEUTICS, INC. (US) 2022-04-21 — — WO disclosed
Send feedback